Vol 2005, No 55 (2005)

Table of Contents

Research & Development

MedImmune Seeks Portfolio Expansion with Medarex Collaboration Abstract pdf
Business Review Editor
AstraZeneca Takes Stake in Cambridge Antibody Technology alongside Antibody Discovery Alliance Abstract pdf
Business Review Editor

Features

Bayer: Seeking Reformulation Abstract pdf
Business Review Editor
Medarex's Second Recent US$0.5 B Deal Abstract pdf
Business Review Editor
Latin America: A Changing Landscape Abstract pdf
Business Review Editor
Therapy Focus: Inflammatory Bowel Disease Abstract pdf
Business Review Editor

Licensing

Serono and Nautilus Sign Hormone Agreement Abstract pdf
Business Review Editor

General

Forest Bolsters its CNS Portfolio Abstract
Business Review Editor

Company Profile

Recordati SpA Abstract pdf
Business Review Editor

Distribution & Marketing

Genzyme Reacquires Arthritis Pain Treatment from Wyeth Abstract pdf
Business Review Editor

Business Commentaries

Seeking the 'Delta' html
Fintan Walton

Deal Trackers

Tarceva (erlotinib) Abstract pdf
Business Review Editor

Mergers & Acquisitions

Agis Puts an End to Merger Rumours Abstract pdf
Business Review Editor
Dainippon and Sumitomo Follow in the Footsteps of Yamanouchi and Fujisawa Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.